Sequencing Reagents Market Size

  • Report ID: 5883
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT

Sequencing Reagents Market Outlook:

Sequencing Reagents Market size was valued at USD 9.73 billion in 2025 and is likely to cross USD 25.7 billion by 2035, expanding at more than 10.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of sequencing reagents is assessed at USD 10.62 billion.

The quick development in sequencing technology will primarily propel the market of market by the end of 2036. Illumina sequencing creation, sequencing by blend (SBS), may be an extensively approved next-generation sequencing (NGS) creation across the globe. Illumina sequencing instruments and reagents back considerably parallel sequencing utilizing an exclusive plan that acknowledges single bases as they are connected into growing DNA strands.

Another reason behind the massive growth of the sequencing reagents market is the limited costs of genetic sequencing. The HGP included beginning with mapping and after that sequencing the human genome. The previous was required at the time since there was something else no 'framework' for organizing the real sequencing or the coming about arrangement information. The maps of the human genome served as 'scaffolds' on which to put through personal portions of amassed DNA grouping. These genome-mapping endeavors were very costly but were basic at the time for producing an exact genome arrangement. It is troublesome to appraise the costs related to the 'human genome mapping phase' of the HGP, but it was certainly within the numerous tens of millions of dollars. The evaluation has taken a toll on creating that beginning 'draft' human genome arrangement is approximately USD 300 million around the world, of which NIH generally has 50-60%.


Sequencing Reagents Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of sequencing reagents is assessed at USD 10.62 billion.

The global sequencing reagents market size was valued at over USD 9.73 billion in 2025 and is expected to expand at a CAGR of over 10.2%, surpassing USD 25.7 billion revenue by 2035.

North America sequencing reagents market achieves a 34% share by 2035, fueled by the region’s advanced healthcare system and leadership in medical innovations.

Key players in the market include Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, BGI, Pacific Biosciences of California, Inc., F. Hoffmann-La Roche A.G., Oxford Nanopore Technologies, Agilent Technologies, Inc., Fluidigm Corporation, ArcherDX, Inc., Myriad Genetics. Inc., Eurofins Scientific, Takara Bio Inc., Mitsui Information Co., Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos